You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2

Article metrics

Article menu

Download PDFPDF

Psoriatic arthritis
Original research
Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2

 

Online download statistics by month:

Online download statistics by month: June 2022 to August 2024

AbstractFullPdf
Jun 2022584595202
Jul 202229529098
Aug 202210911150
Sep 202210810958
Oct 2022848349
Nov 2022595627
Dec 2022463818
Jan 2023726442
Feb 2023737252
Mar 2023615839
Apr 2023444133
May 2023484325
Jun 2023464827
Jul 2023535323
Aug 2023292712
Sep 202335329
Oct 2023645627
Nov 2023504613
Dec 2023404010
Jan 2024453522
Feb 2024444029
Mar 2024544962
Apr 2024373419
May 2024574722
Jun 2024615426
Jul 2024575225
Aug 2024222215
Total227721951034